Correction to: Effect of Gestational Exposure of Cypermethrin on Postnatal Development of Brain Cytochrome P450 2D1 and 3A1 and Neurotransmitter Receptors (Molecular Neurobiology, (2015), 52, 1, (741-756), 10.1007/s12035-014-8903-6);Effect of Gestational Exposure of Cypermethrin on Postnatal Development of Brain Cytochrome P450 2D1 and 3A1 and Neurotransmitter Receptors

Molecular Neurobiology

Volumn 52, Issue 1, 2015, Pages 741-756

  Singh, Anshuman ^a,b   Mudawal, Anubha ^a   Shukla, Rajendra K ^a   Yadav, Sanjay ^a   Khanna, Vinay K ^a   Sethumadhavan, Rao ^b   Parmar, Devendra ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b VIT UNIVERSITY   (India)

Author keywords

Behavior; CYPs; Gestation; Neurotransmitter receptors; Rechallenge

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CYPERMETHRIN; CYTOCHROME P450 2D1; CYTOCHROME P450 3A1; DOPAMINE RECEPTOR; MESSENGER RNA; MUSCARINIC RECEPTOR; NEUROTRANSMITTER RECEPTOR; SEROTONIN RECEPTOR; ALCOHOL DEHYDROGENASE; CYP2D1 PROTEIN, RAT; CYP3A23 PROTEIN, RAT; CYTOCHROME P450; ISOENZYME; PYRETHROID; UNSPECIFIC MONOOXYGENASE;

ADULT; ADULTHOOD; ANIMAL EXPERIMENT; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DRUG RECHALLENGE; ENZYME INDUCTION; FEMALE; GESTATION PERIOD; LOCOMOTION; MALE; NEUROTRANSMISSION; NEWBORN; NONHUMAN; POSTNATAL DEVELOPMENT; PRENATAL DRUG EXPOSURE; PROGENY; PROTEIN EXPRESSION; RAT; RECEPTOR BINDING; ANIMAL; BRAIN; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PREGNANCY; PRENATAL EXPOSURE; REAL TIME POLYMERASE CHAIN REACTION; SYNAPTOSOME; WESTERN BLOTTING; WISTAR RAT;

ALCOHOL OXIDOREDUCTASES; ANIMALS; ANIMALS, NEWBORN; ARYL HYDROCARBON HYDROXYLASES; BLOTTING, WESTERN; BRAIN; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; ISOENZYMES; MALE; MOTOR ACTIVITY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PYRETHRINS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, NEUROTRANSMITTER; RNA, MESSENGER; SYNAPTOSOMES;

EID: 84937968423     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-019-01747-x     Document Type: Erratum

References (57)

1. Shafer TJ, Meyer DA, Crofton KM (2005) Developmental neurotoxicity of pyrethroid insecticides: critical review and future research needs. Environ Health Perspect 113(2):123
2. Bjorling-Poulsen M, Andersen HR, Grandjean P (2008) Potential developmental neurotoxicity of pesticides used in Europe. Environ Heal 7(1):50
3. Eriksson P (1996) Developmental neurotoxicity of environmental agents in the neonate. Neurotoxicology 18(3):719–726
4. London L, Beseler C, Bouchard MF, Bellinger DC, Colosio C, Grandjean P, Harari R, Kootbodien T, Kromhout H, Little F (2012) Neurobehavioral and neurodevelopmental effects of pesticide exposures. Neurotoxicology 33(4):887–896
5. Ray DE, Fry JR (2006) A reassessment of the neurotoxicity of pyrethroid insecticides. Pharmacol Ther 111(1):174–193
6. Crofton KM, Reiter LW (1987) Pyrethroid insecticides and the gamma-aminobutyric acid A receptor complex: motor activity and the acoustic startle response in the rat. J Pharmacol Exp Ther 243(3):946–954
7. Ray DE, Ray D, Forshaw PJ (2000) Pyrethroid insecticides: poisoning syndromes, synergies, and therapy. Clin Toxicol 38(2):95–101
8. Aziz MH, Agrawal AK, Adhami VM, Shukla Y, Seth PK (2001) Neurodevelopmental consequences of gestational exposure (GD14-GD20) to low dose deltamethrin in rats. Neurosci Lett 300(3):161–165
9. Ansari RW, Shukla RK, Yadav RS, Seth K, Pant AB, Singh D, Agrawal AK, Islam F, Khanna VK (2012) Cholinergic dysfunctions and enhanced oxidative stress in the neurobehavioral toxicity of lambda-cyhalothrin in developing rats. Neurotoxicol Res 22(4):292–309
10. Ansari RW, Shukla RK, Yadav RS, Seth K, Pant AB, Singh D, Agrawal AK, Islam F, Khanna VK (2012) Involvement of dopaminergic and serotonergic systems in the neurobehavioral toxicity of lambda-cyhalothrin in developing rats. Toxicol Lett 211(1):1–9
11. Malaviya M, Husain R, Seth PK (1993) Perinatal effects of two pyrethroid insecticides on brain neurotransmitter function in the neonatal rat. Vet Hum Toxicol 35(2):119–122
12. Dayal M, Parmar D, Dhawan A, Dwivedi UN, Doehmer J, Seth PK (1999) Induction of rat brain and liver cytochrome P450 1A1/1A2 and 2B1/2B2 isoenzymes by deltamethrin. Environ Toxicol Pharmacol 7(3):169–178
13. Dayal M, Parmar D, Dhawan A, Ali M, Dwivedi UN, Seth PK (2003) Effect of pretreatment of cytochrome P450 (P450) modifiers on neurobehavioral toxicity induced by deltamethrin. Food Chem Toxicol 41(3):431–437
14. Harvey BH, Oosthuizen F, Brand L, Wegener G, Stein DJ (2004) Stress-restress evokes sustained iNOS activity and altered GABA levels and NMDA receptors in rat hippocampus. Psychopharmacology 175(4):494–502
15. Kroetz DL, Zeldin DC (2002) Cytochrome P450 pathways of arachidonic acid metabolism. Curr Opin Lipidol 13(3):273–283
16. Puga A, Tomlinson CR, Xia Y (2005) Ah receptor signals cross-talk with multiple developmental pathways. Biochem Pharmacol 69(2):199–207
17. Schumacher M, Weill-Engerer S, Liere P, Robert F, Franklin RJM, Garcia-Segura LM, Lambert JJ, Mayo W, Melcangi RC, Parducz A (2003) Steroid hormones and neurosteroids in normal and pathological aging of the nervous system. Prog Neurobiol 71(1):3–29
18. Miksys SL, Tyndale RF (2002) Drug-metabolizing cytochrome P450s in the brain. J Psychiatry Neurosci 27(6):406
19. Scollon EJ, Starr JM, Godin SJ, DeVito MJ, Hughes MF (2009) In vitro metabolism of pyrethroid pesticides by rat and human hepatic microsomes and cytochrome P450 isoforms. Drug Metab Dispos 37(1):221–228
20. Monostory K, Dvorak Z (2011) Steroid regulation of drug-metabolizing cytochromes P450. Curr Drug Metab 12(2):154–172
21. Dutheil F, Beaune P, Loriot M-A (2008) Xenobiotic metabolizing enzymes in the central nervous system: contribution of cytochrome P450 enzymes in normal and pathological human brain. Biochimie 90(3):426–436
22. Ferguson CS, Tyndale RF (2011) Cytochrome P450 enzymes in the brain: emerging evidence of biological significance. Trends Pharmacol Sci 32(12):708–714
23. Gervasini G, Martinez C, Benitez J, Agandez JAG (2007) Effect of neurotransmitters on NADPH-cytochrome P450 reductase in vitro activity. Drug Metab Lett 1(3):172–175
24. Bromek E, Haduch A, Władysława AD (2010) The ability of cytochrome P450 2D isoforms to synthesize dopamine in the brain: an in vitro study. Eur J Pharmacol 626(2):171–178
25. Haduch A, Bromek E, Władysława AD (2013) Role of brain cytochrome P450 (CYP2D) in the metabolism of monoaminergic neurotransmitters. Pharmacol Rep 65(6):1519–1528
26. Haduch A, Bromek E, Sadakierska-Chudy A, Wajcikowski J, Władysława AD (2013) The catalytic competence of cytochrome P450 in the synthesis of serotonin from 5-methoxytryptamine in the brain: an in vitro study. Pharmacol Res 67(1):53–59
27. Nissbrandt H, Bergquist F, Jonason J, Engberg G (2001) Inhibition of cytochrome P450 2E1 induces an increase in extracellular dopamine in rat substantia nigra: a new metabolic pathway? Synapse 40(4):294–301
28. Shahabi HN, Andersson DR, Nissbrandt H (2008) Cytochrome P450 2E1 in the substantia nigra: relevance for dopaminergic neurotransmission and free radical production. Synapse 62(5):379–388
29. Vaglini F, Pardini C, Viaggi C, Corsini GU (2001) Cytochrome p450 and parkinsonism: protective role of CYP2E1. Funct Neurol 16(4; SUPP):107–112
30. A central benzodiazepine receptor and peripheral benzodiazepine receptor ligands as inducers of phenobarbital-inducible CYP2B and CYP3A. Biochem Pharmacol 68(7):1383–1389
31. Singh A, Yadav S, Srivastava V, Kumar R, Singh D, Sethumadhavan R, Parmar D (2013) Imprinting of cerebral and hepatic cytochrome P450s in rat offsprings exposed prenatally to low doses of cypermethrin. Mol Neurobiol 48(1):128–140
32. Iversen LL, Glowinski J (1966) Regional studies of catecholamines in the rat brain-II. J Neurochem 13(8):671–682
33. Parmar D, Dhawan A, Seth PK (1998) Evidence for O-dealkylation of 7-pentoxyresorufin by cytochrome P450 2B1/2B2 isoenzymes in brain. Mol Cell Biochem 189(1–2):201–205
34. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193(1):265–275
35. Yamaguchi M, Yamauchi A, Nishimura M, Ueda N, Naito S (2005) Soybean oil fat emulsion prevents cytochrome P450 mRNA down-regulation induced by fat-free overdose total parenteral nutrition in infant rats. Biol Pharm Bull 28(1):143–147
36. Andoh H, Yoshikawa M, Kawaguchi M, Matsumoto H, Yamazaki K, Oka T (2006) The selective action of D2 dopamine receptor antisense oligodeoxynucleotide on the expression of the dopamine receptor subtype mRNA in rat striatum. Tokai J Exp Clin Med 31(2):73–77
37. Borges MO, Abreu ML, Porto CS, Avellar MC (2001) Characterization of muscarinic acetylcholine receptor in rat Sertoli cells. Endocrinology 142(11):4701–4710
38. Li H, Kraus A, Wu J, Huguenard JR, Fisher RS (2006) Selective changes in thalamic and cortical GABAA receptor subunits in a model of acquired absence epilepsy in the rat. Neuropharmacology 51(1):121–128
39. Ruddell RG, Oakley F, Hussain Z, Yeung I, Bryan-Lluka LJ, Ramm GA, Mann DA (2006) A role for serotonin (5-HT) in hepatic stellate cell function and liver fibrosis. Am J Pathol 169(3):861–876
40. Miksys S, Rao Y, Sellers EM, Kwan M, Mendis D, Tyndale RF (2000) Regional and cellular distribution of CYP2D subfamily members in rat brain. Xenobiotica 30(6):547–564
41. Yadav S, Dhawan A, Seth PK, Singh RL, Parmar D (2006) Cytochrome P4503A: evidence for mRNA expression and catalytic activity in rat brain. Mol Cell Biochem 287(1–2):91–99
42. Khanna VK, Husain R, Seth PK (1994) Effect of protein malnutrition on the neurobehavioural toxicity of styrene in young rats. J Appl Toxicol 14(5):351–356
43. Anadon A, Martinez-Larranaga MR, Fernandez-Cruz ML, Diaz MJ, Fernandez MC, Martinez MA (1996) Toxicokinetics of deltamethrin and its 4′-OH-metabolite in the rat. Toxicol Appl Pharmacol 141(1):8–16
44. Yadav S, Johri A, Dhawan A, Seth PK, Parmar D (2006) Regional specificity in deltamethrin induced cytochrome P450 expression in rat brain. Toxicol Appl Pharmacol 217(1):15–24
45. Schoedel KA, Sellers EM, Tyndale RF (2001) Induction of CYP2B1/2 and nicotine metabolism by ethanol in rat liver but not rat brain. Biochem Pharmacol 62(8):1025–1036
46. Mäenpää J, Pelkonen O, Cresteil T, Rane A (1993) The role of cytochrome P450 3A (CYP3A) isoform(s) in oxidative metabolism of testosterone and benzphetamine in human adult and fetal liver. J Steroid Biochem Mol Biol 44(1):61–67
47. Nebert DW, Russell DW (2002) Clinical importance of the cytochromes P450. Lancet 360(9340):1155–1162
48. Hossain MM, Suzuki T, Sato I, Takewaki T, Suzuki K, Kobayashi H (2004) The modulatory effect of pyrethroids on acetylcholine release in the hippocampus of freely moving rats. Neurotoxicology 25(5):825–833
49. Hossain MM, Suzuki T, Unno T, Komori S, Kobayashi H (2008) Differential presynaptic actions of pyrethroid insecticides on glutamatergic and GABAergic neurons in the hippocampus. Toxicology 243(1):155–163
50. Daniels WMU, Pietersen CY, Carstens ME, Stein DJ (2004) Maternal separation in rats leads to anxiety-like behavior and a blunted ACTH response and altered neurotransmitter levels in response to a subsequent stressor. Metab Brain Dis 19(1–2):3–14
51. Martinez-Larranaga MR, Anadon A, Martinez MA, Martinez M, Castellano VJ, Diaz MJ (2003) 5-HT loss in rat brain by type II pyrethroid insecticides. Toxicol Ind Health 19:147–155
52. Cahir M, Ardis T, Reynolds GP, Cooper SJ (2007) Acute and chronic tryptophan depletion differentially regulate central 5-HT1A and 5-HT2A receptor binding in the rat. Psychopharmacology 190(4):497–506
53. 2 receptors. Neuropharmacology 24(12):1201–1205
54. 2A receptor binding, but not mGluR2, is increased in tryptophan hydroxylase 2 decrease-of-function mice. Neurosci Lett 555:118–122
55. Niznik HB, Tyndale RF, Sallee FR, Gonzalez FJ, Hardwick JP, Inaba T, Kalow W (1990) The dopamine transporter and cytochrome P450IID1 (debrisoquine 4-hydroxylase) in brain: resolution and identification of two distinct [3H]GBR-12935 binding proteins. Arch Biochem Biophys 276(2):424–432
56. Riedl AG, Watts PM, Edwards RJ, Schulz-Utermoehl T, Boobis AR, Jenner P, Marsden CD (1999) Expression and localisation of CYP2D enzymes in rat basal ganglia. Brain Res 822(1):175–191
57. Martinez C, Gervasini G, Agundez JAG, Carrillo JA, Ramos SI, Garcia-Gamito FJ, Gallardo L, Benitez J (2000) Modulation of midazolam 1-hydroxylation activity in vitro by neurotransmitters and precursors. Eur J Clin Pharmacol 56(2):145–151